Serum metabolomic profiles associated with psychoneurological symptoms in women with early-stage breast cancer over one year
Frontiers in Oncology · 12.03.2026 · 16
DOI: 10.3389/fonc.2026.1779012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 12.03.2026. Verfasst von Gee Su Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, University of Connecticut, Storrs, CT, United States. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINR NIH HHS, National Institute of Nursing Research.
Abstract (Originalsprache)
Background
Breast cancer survivors frequently experience psychoneurological symptoms (PNS), such as pain, fatigue, anxiety, depression, and sleep disturbances, that persist beyond treatment and impair quality of life. Inflammatory and metabolic dysregulation, including alterations in the tryptophan/kynurenine pathway, have been implicated, yet longitudinal data and racial differences remain understudied. This study examined the longitudinal association between metabolite levels and PNS severity over time and explored their interactions with race.
Methods
In a one-year longitudinal secondary data analysis, we performed untargeted serum metabolomic profiling and applied generalized estimating equations (GEE), adjusting for demographic covariates. Interaction terms were included to evaluate race-specific metabolite associations. Metabolite set enrichment analysis was conducted to identify impacted metabolic super-pathways using MetaboAnalyst 6.0.
Results
Among 74 participants, we identified 140 metabolites significantly associated with PNS out of the 2,395 metabolites tested, with 38 named metabolites. Anxiety was associated with 2-aceto-2-hydroxy-butanoate (β=-2.40, p=5.79×10-6) and 1-pyrrolidinecarboxaldehyde (β=-0.753, p=8.61×10-6), while sleep disturbance associated with 4,6-O-ethylidene-D-glucose (β=9.83, p=4.82×10-6) and 5-hydroxytryptophol (β=7.82, p=5.55×10-4). Fatigue showed the most associations, including 3-hydroxystachydrine (β=1.02, p=3.79×10-8) and N-acetylglycine (β=0.927, p=5.89×10-5), and pain were associated with inulin (β=-3.19, p=5.39×10-5). Associations between race and PNS–metabolite interactions revealed unique patterns for Black women, particularly for sleep disturbances, pain and fatigue. Taurine/hypotaurine and cysteine metabolism were the most impacted pathways in the enrichment analysis.
Conclusions
These findings highlight distinct metabolite profiles underlying PNS and suggest that sulfur amino acid- and oxidative stress-related pathways may contribute to symptom variability. Specific metabolites may reflect underlying metabolic pathway differences across racial groups. These results provide a foundation for future mechanistic studies and metabolically targeted interventions in cancer survivorship.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Nursing, University of Connecticut, Storrs, CT, United States.
- Division of Nursing Science, School of Nursing, Rutgers University, New Brunswick, NJ, United States.
- Department of Biostatistics, University of Florida & Division of Quantitative Sciences, University of Florida Health Cancer Institute, Gainesville, FL, United States.
- Division of Quantitative Sciences, University of Florida Health Cancer Institute, Gainesville, FL, United States.
- Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, United States.
- Biobehavioral Nursing Science, College of Nursing, University of Florida, Gainesville, FL, United States.
Förderung
- NINR NIH HHS
- National Institute of Nursing Research
Zitieren
APA
Yang, G. S., Starkweather, A., Lin, T., Hashemian, T., Garrett, T. J., Fanfan, D., Cousin, L., Patel, S., Kelly, D. L., & Lyon, D. E. (2026). Serum metabolomic profiles associated with psychoneurological symptoms in women with early-stage breast cancer over one year. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1779012
Vancouver
Yang GS, Starkweather A, Lin T, Hashemian T, Garrett TJ, Fanfan D, et al. Serum metabolomic profiles associated with psychoneurological symptoms in women with early-stage breast cancer over one year. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1779012
BibTeX
@article{Yang2026,
author = {Yang, Gee Su and Starkweather, Angela and Lin, Tuo and Hashemian, Tara and Garrett, Timothy J and Fanfan, Dany and Cousin, Lakeshia and Patel, Shreya and Kelly, Debra Lynch and Lyon, Debra E},
title = {Serum metabolomic profiles associated with psychoneurological symptoms in women with early-stage breast cancer over one year},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1779012}
}
EUVIMED